SBWire

If you’ve had one too many drinks, awoken with a dry mouth, pounding headache and nausea you’re probably suffering from a hangover. But if you added cigarette smoking to the equation, you’ve definitely made your hangover even worse. South Beach Smoke, electronic cigarettes, can help give the smokers their nicotine fix without suffering from a dreadful hangover the next morning.

The Bulgarian insurance industry grew at a compound annual growth rate (CAGR) of 1.5% during the review period (2007-2011). The Bulgarian life insurance segment is highly-concentrated. There has been little change in terms of segment concentration during the review period. Furthermore, almost all of the key life insurers are owned by foreign entities. Bulgaria's insurance industry is dominated by the non-life segment. Motor insurance is the largest category within the segment as third-party liability insurance is mandatory by law. In October 2011, Vienna Insurance Group announced that it would be merging Bulstrad with Bulgarski Imoti, which is expected to increase the group's market share to 16% of the non-life segment.

In 2011, 7,604 divorces and annulments were granted in Singapore, according to the Singapore Department of Statistics, with the majority coming under the Women's Charter and the rest under the Administration of Muslim Law Act. Under the Women's Charter, the most common reason for divorce was 'unreasonable behaviour' in contrast to divorces under the Administration of Muslim Law Act where 'infidelity or extra-martial affair' was the top reason for divorcing. If one suspects his or her wife is having an affair, a Singapore private investigator becomes necessary to ensure fair representation during legal proceedings, Vincent Tan of Commercial Investigation LLP states.

oo.sg is offering 40% off on the best books of November on Amazon. On every book buy customers can save a lot at this online bookstore in Singapore, a website that consolidates the best deals from 9 websites like the Amazon, Kinokuniya, Popular, Betterworldbooks, Bookdeposiitory, Fishpond and many more. Discount is available on editor’s top ten picks for November.

Priority One Jets, Inc., a leader in private jet charter travel and business aviation, recently announced a special promotion relating to their innovative SkyCard membership program. The company will begin offering the first $2,500 (USD) spent on the card free of charge as a special gift to new members.

Finding the right realtor can be difficult – especially for those who are just moving to a new area. But with a little online research, it doesn’t take long to figure out which real estate agency offers the best blend of affordable commission rates and friendly customer service.

Nobody likes getting old. The body starts to break down, skin starts to sag, and health problems gradually build up. But thanks to recent significant advancements in the health supplement industry, aging is becoming more manageable.

When you’ve lost a loved one, the last thing you want to do is deal with all of the things that need to be dealt with straight away – but sometimes, the most time sensitive thing you need to do is deal with your house. We are experts in solving and dealing with the problems that come with estate management and property disposal.

Phen375 reviews have just been added to BestAppetiteSuppressantPills.com, a website that focuses on offering people unbiased, in-depth and helpful reviews about a wide variety of appetite suppressants, diet pills and fat burners.

Human Papillomavirus Infections - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Human Papillomavirus Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Human Papillomavirus Infections.

Cancer Pain - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cancer Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cancer Pain.

Dengue - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Dengue, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dengue.

Diarrhea - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diarrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diarrhea.

Hypercholesterolemia - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hypercholesterolemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypercholesterolemia.

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Leishmaniasis (Kala-Azar), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Leishmaniasis (Kala-Azar).

Diabetic Foot Ulcers - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Foot Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Foot Ulcers.

Candidiasis - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Candidiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Candidiasis.

Diabetic Nephropathy - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Nephropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Nephropathy.

Menopausal Disorders - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Disorders.

Back Pain - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Back Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Back Pain.

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Onychomycosis (Tinea Unguium), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Onychomycosis (Tinea Unguium).

Opium (Opioid) Addiction - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Opium (Opioid) Addiction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Opium (Opioid) Addiction.

Alopecia - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Alopecia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Alopecia.

Dyskinesia - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Dyskinesia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dyskinesia.

Macular Edema - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Macular Edema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Macular Edema.